Argent Trust Co’s Novartis NVS Stock Holding History

Argent Trust Co’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.85M	Sell	38,288 -2,045	-5%	-$313K	0.2%	122
2025 Q4	$5.56M	Buy	40,333 +291	+0.7%	+$38.1K	0.19%	116
2025 Q3	$5.13M	Buy	40,042 +1,147	+3%	+$140K	0.18%	122
2025 Q2	$4.71M	Buy	38,895 +2,038	+6%	+$230K	0.18%	123
2025 Q1	$4.11M	Buy	36,857 +1,234	+3%	+$131K	0.17%	128
2024 Q4	$3.47M	Buy	35,623 +608	+2%	+$64.8K	0.14%	139
2024 Q3	$4.03M	Sell	35,015 -560	-2%	-$63.5K	0.17%	126
2024 Q2	$3.79M	Buy	35,575 +1,574	+5%	+$158K	0.17%	125
2024 Q1	$3.29M	Sell	34,001 -417	-1%	-$42.8K	0.15%	146
2023 Q4	$3.48M	Sell	34,418 -351	-1%	-$33.9K	0.17%	129
2023 Q3	$3.54M	Sell	34,769 -152	-0.4%	-$15.4K	0.19%	117
2023 Q2	$3.52M	Sell	34,921 -840	-2%	-$84K	0.19%	117
2023 Q1	$3.29M	Buy	35,761 +1,323	+4%	+$116K	0.21%	111
2022 Q4	$3.12M	Sell	34,438 -2,863	-8%	-$241K	0.21%	108
2022 Q3	$2.83M	Buy	37,301 +857	+2%	+$71K	0.21%	107
2022 Q2	$3.08M	Sell	36,444 -156	-0.4%	-$13.7K	0.21%	106
2022 Q1	$3.21M	Sell	36,600 -253	-0.7%	-$21.9K	0.2%	116
2021 Q4	$3.22M	Sell	36,853 -1,320	-3%	-$110K	0.19%	119
2021 Q3	$3.12M	Buy	38,173 +169	+0.4%	+$15.2K	0.2%	112
2021 Q2	$3.47M	Buy	38,004 +339	+0.9%	+$30.2K	0.23%	103
2021 Q1	$3.22M	Buy	37,665 +906	+2%	+$81.3K	0.23%	102
2020 Q4	$3.47M	Sell	36,759 -3,139	-8%	-$274K	0.27%	88
2020 Q3	$3.47M	Buy	39,898 +1,661	+4%	+$144K	0.31%	78
2020 Q2	$3.34M	Buy	38,237 +3,709	+11%	+$320K	0.31%	77
2020 Q1	$2.85M	Sell	34,528 -733	-2%	-$65.4K	0.32%	73
2019 Q4	$3.34M	Buy	35,261 +381	+1%	+$34.2K	0.3%	84
2019 Q3	$3.03M	Buy	34,880 +4,321	+14%	+$388K	0.29%	84
2019 Q2	$2.79M	Sell	30,559 -3,268	-10%	-$277K	0.28%	89
2019 Q1	$2.91M	Buy	33,827 +1,806	+6%	+$145K	0.31%	84
2018 Q4	$2.46M	Buy	32,021 +16,803	+110%	+$1.31M	0.29%	89
2018 Q3	$1.18M	Buy	15,218 +1,116	+8%	+$82.5K	0.14%	156
2018 Q2	$954K	Sell	14,102 -304	-2%	-$21K	0.12%	175
2018 Q1	$1.04M	Buy	14,406 +4,651	+48%	+$354K	0.3%	78
2017 Q4	$734K	Sell	9,755 -210	-2%	-$15.8K	0.29%	108
2017 Q3	$767K	Buy	9,965 +112	+1%	+$8.46K	0.3%	100
2017 Q2	$737K	Buy	9,853 +928	+10%	+$65.8K	0.3%	100
2017 Q1	$594K	Buy	8,925 +1,621	+22%	+$108K	0.25%	128
2016 Q4	$476K	Sell	7,304 -2,830	-28%	-$184K	0.21%	150
2016 Q3	$717K	Buy	10,134 +2,052	+25%	+$150K	0.3%	99
2016 Q2	$597K	Buy	8,082 +2,119	+36%	+$146K	0.26%	122
2016 Q1	$387K	Buy	+5,963	New	+$406K	0.19%	158

Other funds holding NVS

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Argent Trust Co's NVS Position: Q1 2026 in Review

Argent Trust Co reduced its Novartis (NVS) stake by 5.1% in Q1 2026, selling an estimated $313K and leaving 38,288 shares worth $5.85M. The position accounts for 0.2% of the portfolio, ranked #122.

Argent Trust Co first reported a position in NVS in Q1 2016 and has held it in 41 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

Argent Trust Co held 38,288 shares of Novartis worth $5.85M as of Q1 2026.
Argent Trust Co sold 2,045 Novartis shares in Q1 2026, an estimated $313K.
Novartis made up 0.2% of Argent Trust Co's portfolio in Q1 2026, its #122 holding.
Argent Trust Co first reported a position in Novartis in Q1 2016 and has held it in 41 quarters since.
1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on Argent Trust Co's 13F filing for Q1 2026, filed 13 May 2026.